Cardiovascular Safety of Sitagliptin in Patients With Type 2 Diabetes Mellitus: A Pooled Analysis

Cardiovascular Diabetology - United Kingdom
doi 10.1186/1475-2840-12-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sitagliptin Improves Albuminuria in Patients With Type 2 Diabetes Mellitus

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2013English

Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus

Journal of Clinical Medicine Research
2014English

Efficacy and Safety of Canagliflozin Compared With Placebo in Older Patients With Type 2 Diabetes Mellitus: A Pooled Analysis of Clinical Studies

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2014English

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

Cureus
2017English

Effect of Sitagliptin on Diabetic Profile of Type 2 Diabetes Mellitus Patients

International Journal of Contemporary Medical Research [IJCMR]
2019English

The Durability of Sitagliptin in Elderly Patients With type 2 Diabetes

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2014English

A Retrospective Comparison Study Between the Effectiveness and Safety of Fixed Dose Combination of Vildagliptin Versus Sitagliptin With Metformin in Type 2 Diabetes Mellitus Patients

Indian Journal of Pharmacy Practice
2018English

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

Advances in Therapy
MedicinePharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy